Radiation pneumonitis in patients with lung and mediastinal tumours: A retrospective study of risk factors focused on pulmonary emphysema

British Journal of Radiology

Volumn 85, Issue 1010, 2012, Pages 135-141

  Kimura, Tomoki ^a,b   Togami, T ^a   Takashima, H ^c   Nishiyama, Y ^a   Ohkawa, M ^a   Nagata, Y ^b  

^a KAGAWA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c Takinomiya General Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INCIDENCE; LUNG EMPHYSEMA; LUNG NON SMALL CELL CANCER; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM TUMOR; RADIATION DOSE; RADIATION PNEUMONIA; RISK FACTOR; SMALL CELL CARCINOMA;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MEDIASTINAL NEOPLASMS; MIDDLE AGED; PULMONARY EMPHYSEMA; RADIATION PNEUMONITIS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SMALL CELL LUNG CARCINOMA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84857244961     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/32629867     Document Type: Article

References (21)

1. Fukuchi Y, Nishimura M, Ichinose M, Adachi M, Nagai A, Kuriyama T, et al. COPD in Japan: the Nippon COPD Epidemiology study. Respirology 2004;9:458-63.
2. American Thoracic Society. Standard for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987;136:225-32.
3. The Japanese Respiratory Society, ed. Guideline of COPD (chronic obstructive pulmonary disease) for diagnosis and treatment. 2nd edn. Tokyo: Medical View, 2004.
4. Sekine Y, Behnia M, Fujisawa T. Impact of COPD on pulmonary complications and on long-term survival of patients undergoing surgery for NSCLC. Lung Cancer 2002;37:95-101. (Pubitemid 34621464)
5. Graham MV, Purdy JA, Emami B, Harma W, Bosch W, Lockett MA, et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 1999;45:323-9. (Pubitemid 29408545)
6. Tsujino K, Hirota S, Endo M, Obayashi K, Kotani Y, Satouchi M, et al. Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 2003;55:110-15. (Pubitemid 36020349)
7. Yorke ED, Jackson A, Rosenzweig KE, Braban L, Leibel SA, Ling CCL. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys 2005;63:672-82. (Pubitemid 41400051)
8. Kong FM, Hayman JA, Griffith KA, Kalemkerian GP, Arenberg D, Lyons S, et al. Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis. Int J Radiat Oncol Biol Phys 2006; 63:672-82.
9. Rancati T, Ceresoli GL, Gagliardi G, Schipani S, Cattaneo GM. Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study. Radiother Oncol 2003;67:275-83. (Pubitemid 36831080)
10. Kocak Z, Evans ES, Zhou SM, Miller KL, Folz RJ, Shafman TD, et al. Challenges in defining radiation pneumonitis in patients with lung cancer. Int J Radiat Oncol Biol Phys 2005;62:635-8. (Pubitemid 40779747)
11. Borst GR, Jaeger KD, Belderbos JSA, Burgers SA, Lebesque JV. Pulmonary function changes after radiotherapy in non-small-cell lung cancer patients with long-term disease- free survival. Int J Radiat Oncol Biol Phys 2005;62: 639-44. (Pubitemid 40779748)
12. Nishiyama Y, Yamamoto Y, Kimura N, Ishikawa S, Sasakawa Y, Ohkawa M. Dual-time-point FDG-PET for evaluation of lymph node metastasis in patients with nonsmall lung cancer. Ann Nucl Med 2008;22:245-50. (Pubitemid 351809786)
13. Satoh K, Kobayashi T, Misao T, Hitani Y, Yamamoto Y, Nishiyama Y, et al. CT assessment of subtypes of pulmonary emphysema in smokers. Chest 2001;120:725-9. (Pubitemid 32885441)
14. Lee IH, Hayman JA, Landrum MB, Tepper J, Tao ML, Goodman KA, et al. Treatment recommendations for locally advanced, non-small-cell lung cancer: the influence of physician and patient factors. Int J Radiat Oncol Biol Phys 2009;74:1376-84.
15. Jett JR, Schild SE, Keith RL, Kesler KA. Treatment of nonsmall cell lung cancer, stage IIIB: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132:266S-76S. (Pubitemid 47502812)
16. Kimura T, Matsuura K, Murakami Y, Hashimoto Y, Kenjo M, Kaneyasu Y, et al. CT appearance of radiation injury of the lung and clinical symptoms after stereotactic body radiation therapy (SBRT) for lung cancers: are patients with pulmonary emphysema also candidates for SBRT for lung cancers? Int J Radiat Oncol Biol Phys 2006;66:483-91. (Pubitemid 44332732)
17. Rubin P, Johnston CJ, Williams JP, McDonald S, Finkelstein. A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys 1995;33: 99-109.
18. Mehta V. Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: pulmonary function, prediction, and prevention. Int J Radiat Oncol Biol Phys 2005;63:5-24. (Pubitemid 41583538)
19. Yaremko BP, Guerrero TM, Noyola-Martinez J, Guerra R, Lege DG, Nguyen LT, et al. Reduction of normal lung irradiation in locally advanced non-small cell lung cancer patients, using ventilation images for functional avoidance. Int J Radiat Oncol Biol Phys 2007;68:562-71. (Pubitemid 46694185)
20. Shioyama Y, Jang SY, Liu HH, Guerrero T, Wang X, Gayed IW, et al. Preserving functional lung using perfusion imaging and intensity-modulated radiation therapy for advancedstage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2006;68:562-71.
21. Bates EL, Bragg CM, Wild JM, Hatton MQF, Ireland RH. Functional image-based radiotherapy planning for nonsmall cell lung cancer. A simulation study. Radiother Oncol 2009;93:32-6.